Intravenous administration of bare MoS2 nanosheets and drug loading MoS2 nanosheets in mice
This protocol is extracted from research article:
Mass spectrometry imaging of the in situ drug release from nanocarriers
Sci Adv, Oct 31, 2018; DOI: 10.1126/sciadv.aat9039

Bare MoS2 nanosheets were injected into the normal and tumor-bearing mice through the tail vein with the dose of 5 mg/kg. The intravenous doses of MoS2/PEG-DOX used for normal and tumor-bearing mice were 5 mg/kg for MoS2 nanosheets and 3.5 mg/kg for DOX.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.